Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Integra Lifesciences (IART)
Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,245,086
  • Shares Outstanding, K 78,176
  • Annual Sales, $ 1,558 M
  • Annual Income, $ 180,550 K
  • 60-Month Beta 1.18
  • Price/Sales 2.03
  • Price/Cash Flow 8.45
  • Price/Book 2.03
Trade IART with:

Options Overview Details

View History
  • Implied Volatility 39.40% ( +3.09%)
  • Historical Volatility 38.09%
  • IV Percentile 65%
  • IV Rank 61.28%
  • IV High 55.64% on 09/18/23
  • IV Low 13.68% on 08/17/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 5
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 4.58
  • Today's Open Interest 1,027
  • Open Int (30-Day) 1,013

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.90
  • Number of Estimates 8
  • High Estimate 0.91
  • Low Estimate 0.89
  • Prior Year 0.94
  • Growth Rate Est. (year over year) -4.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.81 +14.10%
on 11/10/23
42.49 -3.84%
on 12/05/23
+2.71 (+7.10%)
since 11/06/23
3-Month
33.44 +22.19%
on 10/25/23
42.49 -3.84%
on 12/05/23
-0.54 (-1.30%)
since 09/06/23
52-Week
33.44 +22.19%
on 10/25/23
60.69 -32.67%
on 02/02/23
-13.89 (-25.37%)
since 12/06/22

Most Recent Stories

More News
Integra: Q3 Earnings Snapshot

Integra: Q3 Earnings Snapshot

IART : 40.93 (-1.40%)
IART Investors Have Opportunity to Lead Integra LifeSciences Holdings Corporation Securities Fraud Lawsuit

/PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action...

IART : 40.93 (-1.40%)
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Integra LifeSciences Holdings Corporation(IART) Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART) of a class...

IART : 40.93 (-1.40%)
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Integra LifeSciences Holdings Corporation - IART

/PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Integra LifeSciences Holdings Corporation...

IART : 40.93 (-1.40%)
IART Investors Have Opportunity to Lead Integra LifeSciences Holdings Corporation Securities Fraud Lawsuit

/PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action...

IART : 40.93 (-1.40%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ:...

IART : 40.93 (-1.40%)
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integra LifeSciences Holdings Corporation...

IART : 40.93 (-1.40%)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Integra Investors of a Lead Plaintiff Deadline of November 13, 2023

/PRNewswire/ -- Attention Integra LifeSciences Holdings Corporation ("Integra") (NASDAQ: IART) shareholders: The Law Offices of Vincent Wong announce that a...

IART : 40.93 (-1.40%)
INTEGRA LIFESCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings

/PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have...

IART : 40.93 (-1.40%)
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Integra LifeSciences Holdings Corporation(IART) Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART) of a class...

IART : 40.93 (-1.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty...

See More

Key Turning Points

3rd Resistance Point 44.96
2nd Resistance Point 43.72
1st Resistance Point 42.62
Last Price 40.93
1st Support Level 40.28
2nd Support Level 39.04
3rd Support Level 37.94

See More

52-Week High 60.69
Fibonacci 61.8% 50.28
Fibonacci 50% 47.06
Fibonacci 38.2% 43.85
Last Price 40.93
52-Week Low 33.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar